Skip to main content
Valneva SE logo

Valneva SE — Investor Relations & Filings

Ticker · VLA ISIN · FR0004056851 LEI · 969500DIVIP5VKNW4948 PA Manufacturing
Open in API
Filings indexed 1,663 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country FR France
Listing PA VLA

About Valneva SE

https://valneva.com/

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2026-06-01 English
Franchissement de seuil
Major Shareholding Notification Classification · 95% confidence The document is a Déclaration de franchissement de seuil under article L.233-7 of the French Commercial Code, detailing a shareholder (Caisse des dépôts et consignations) crossing a 10% voting rights threshold in Valneva SE. This is a notification of a significant change in share ownership levels, matching the Major Shareholding Notification category.
2026-05-28 French
6-K - Valneva SE (0001836564) (Filer)
Regulatory Filings
2026-05-13 English
Valneva publie ses résultats financiers audités et consolidés pour le premier trimestre 2026
Earnings Release Classification · 90% confidence The document is a press release announcing Valneva’s first‐quarter 2026 non‐audited consolidated financial results, providing key highlights (revenues, net loss, cash position), narrative commentary on performance and outlook, and details of a conference call. It is an initial earnings announcement rather than a full interim report or a simple publication notice. Therefore, it best fits the Earnings Release category (ER). Q1 2026
2026-05-13 French
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Earnings Release Classification · 89% confidence The document is a press release titled “Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates.” It provides summary highlights, bullet‐point key metrics, CFO commentary, condensed interim financial tables for the quarter ended March 31, 2026, and updated guidance—all hallmarks of an initial quarterly earnings announcement rather than a full interim report or annual document. Q1 2026
2026-05-13 English
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
Earnings Release Classification · 95% confidence The document is a press release announcing the date when Valneva will report its first quarter 2026 consolidated financial results and the details of a live webcast to discuss these results. It does not contain the actual financial results or substantive financial data but rather informs investors and the public about the upcoming earnings release event. The document length is 4112 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as an Earnings Release (ER) announcement or a Report Publication Announcement (RPA). However, since it does not state that the report is attached or available but rather announces the date of the earnings release, it fits the Earnings Release (ER) category as an initial announcement of quarterly financial results. Q1 2026
2026-05-06 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.